Launch of the European project RISK-HUNT3R The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
People born in 1981 invited for COVID-19 vaccination As of today, people born in 1981 can schedule an appointment online via www.coronavaccinatie-afspraak.nl for vaccination by the Municipal Public Health Services (GGDs).
Number of COVID-19 infections continues to increase 1,329 new COVID-19 infections were reported over the past week. That is 342 more confirmed cases reported than the week before that, when 987 new COVID-19 infections were reported.
Number of COVID-19 infections is increasing 987 new COVID-19 infections were reported over the past week. This is nearly twice the number of infections reported in the previous week, when 534 new cases were reported.
Gap between intention and behaviour in staying home and testing for COVID-19 The Dutch policy of staying home and getting tested if you have corona-related symptoms can count on support from the majority of the over 50,000 participants in RIVM’s behavioural study.
About 100 COVID-19 infections detected per week through source and contact tracing The results of 14 days of monitoring of source and contact tracing are known for week 26 (22 to 28 June).
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.